Strategy | Financing Transactions Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $158.3 million of Series B venture funding in a deal led by Deep Track Capital on April 10, 2024. Bristol-Myers Squibb, Perceptive Xontogeny Venture...
Strategy | Financing Transactions Private Placement / Financing Transactions Avenzo: The company raised $223.4 million in Series A venture funding in a deal led by Deep Track Capital, Sands Capital, and Sofinnova Investments on March 27, 2024, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Capstan Therapeutics: The company raised $175 million of Series B venture funding in a deal led by RA Capital Management on March 20, 2024, putting the company’s pre-money valuation at...
Strategy | Financing Transactions Private Placement / Financing Transactions Tubulis: The company raised EUR 128 million of Series B2 venture funding in a deal led by EQT Life Sciences and Nextech Invest on March 14, 2024. Evotec, Andera Partners, Deep Track Capital,...
Strategy | Financing Transactions Private Placement / Financing Transactions Alumis: The company raised $259 million of Series C venture funding in a deal led by Foresite Capital, Samsara BioCapital and venBio on March 6, 2024, putting the company’s pre-money...
Strategy | Financing Transactions Private Placement / Financing Transactions FogPharma: The company raised $145 million of Series E venture funding in a deal led by Nextech Invest on March 1, 2024. GV, Milky Way Investments Group, The Invus Group, Foresite Capital,...
